Want to join the conversation?
On Oct. 28, $ICPT announced results of a 72-week Phase 2 dose ranging trial of OCA in 200 adult patients with NASH in Japan. In this trial, 202 Japanese biopsy-proven NASH patients were randomized into one of four arms to receive either a 10mg, 20mg or 40mg dose of OCA or placebo. The primary endpoints was histologic improvement.
$BA won a $22 billion deal from SpiceJet, their largest order from an Indian airline.
$FB stock remained in the green territory after Raymond James upgraded shares to strong buy from outperform, on expectations that overall 4Q16 ad spending was strong.
$ARRY Good day for the stock, jumped 7%. Great gains !
2017 was supposed to be another record year for automotive industry. Still, $F Ford thinks its profit will dip in 2017..!!
$KKR to buy Hitachi’s power tool unit Hitachi Koki for $1.3 billion. Looks like KKR & Co is going strong in Japan! Remember when it bought Calsonic Kansei a while back?